Inventor · New Hope, PA, US

Jinfa Du

47Patents
20h-index
53Co-inventors
88Inventor score

Filing activity: May 17, 1994 → Nov 16, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7964580B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 156 Active
US8173621B2 Nucleoside cyclicphosphates Chemistry; Metallurgy 106 Active
US8334270B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 102 Active
US8580765B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 80 Active
US7601820B2 Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives Chemistry; Metallurgy 77 Active
US8735372B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 72 Active
US8759510B2 Nucleoside cyclicphosphates Chemistry; Metallurgy 60 Active
US8765710B2 2′,4′-substituted nucleosides as antiviral agents Chemistry; Metallurgy 58 Active
US8716263B2 Synthesis of purine nucleosides Emerging Cross-Sectional Technologies 57 Active
US8841275B2 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections Emerging Cross-Sectional Technologies 52 Active
US8716262B2 Nucleoside phosphoramidates Emerging Cross-Sectional Technologies 49 Active
US8481713B2 Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives Chemistry; Metallurgy 48 Active
US8906880B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 48 Active
US9085573B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 38 Active
US8957046B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 35 Active
US8492539B2 Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives Chemistry; Metallurgy 33 Active
US9045520B2 Synthesis of purine nucleosides Emerging Cross-Sectional Technologies 30 Active
US8569478B2 Modified 4′-nucleosides as antiviral agents Chemistry; Metallurgy 29 Active
US6271212A Prodrug azide compositions and compounds Chemistry; Metallurgy 24 Expired
US8957045B2 Nucleoside phosphoramidates Emerging Cross-Sectional Technologies 23 Active
US6949521B2 Therapeutic azide compounds Chemistry; Metallurgy 12 Expired
US6071922A Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides Chemistry; Metallurgy 12 Expired
US9458145B2 Benzimidazole derivatives as bromodomain inhibitors Chemistry; Metallurgy 11 Active
US9585906B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 11 Active
US9255089B2 Benzimidazolone derivatives as bromodomain inhibitors Chemistry; Metallurgy 7 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.